BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15754732)

  • 1. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
    Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
    Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
    Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
    Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the MEN1 gene in sporadic parathyroid tumors.
    Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2627-30. PubMed ID: 9709922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
    Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.
    Dwight T; Nelson AE; Theodosopoulos G; Richardson AL; Learoyd DL; Philips J; Delbridge L; Zedenius J; Teh BT; Larsson C; Marsh DJ; Robinson BG
    Am J Pathol; 2002 Oct; 161(4):1299-306. PubMed ID: 12368203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
    Klein RD; Salih S; Bessoni J; Bale AE
    Genet Med; 2005 Feb; 7(2):131-8. PubMed ID: 15714081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
    Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
    Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
    Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.